{"accession":"BGC0002844","version":1,"changelog":{"releases":[{"version":"1","entries":[{"contributors":["U45G63MLSP33JST2JZS23R4V","7LZK2REXWMB23Y766VYXAX3J","Q4G2APLPZNOU4XV72H6GYP54","3UOU7PODQJXIM6BEPUHHRRA5"],"reviewers":["AAAAAAAAAAAAAAAAAAAAAAAA"],"date":"2024-07-25","comment":"MIBiG v4 annotathon"}],"date":"2024-11-15"}]},"quality":"high","status":"retired","completeness":"complete","loci":[{"accession":"MDEQ00000000.2","location":{"from":4119,"to":84195},"evidence":[{"method":"In vitro expression","references":["doi:10.1093/jambio/lxae040"]}]}],"biosynthesis":{"classes":[{"class":"NRPS","subclass":"Type I"},{"class":"PKS","subclass":"Type I","cyclases":[]}]},"compounds":[{"name":"burkholdine Bk1215","evidence":[{"method":"NMR","references":["doi:10.1093/jambio/lxae040"]}],"classes":["Lipopeptide"],"bioactivities":[{"name":"antifungal","observed":false,"references":["doi:10.1021/np300108u"],"assays":[{"concentration":"0.15 µg/mL","target":"antifungal"}]}],"structure":"CCCCCCCCCCCC(C(C(CC1CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C(=O)N)O)CO)CC(=O)N)CCN)C(C2=CC=C(C=C2)O)O)CO)O)O)OC3C(C(C(CO3)O)O)O","synonyms":["burkholdine 1215","Burkholdine BK-1215","burkholdine (BK)-1215"],"databaseIds":["pubchem:71454652"],"moieties":["glycosylated lipopeptides"],"cyclic":true,"mass":1216.0,"formula":"C52H85N11O22"}],"taxonomy":{"name":"Bukrholderia  catarinensis 89","ncbiTaxId":1108140},"retirement_reasons":["validation failed"],"comment":"In addition to burkholdine BK1215 (m/z 1216), the BGC (4119–84195 nt) of B. catarinensis 89T has the capability to synthesise other burkholdine analogues (m/z 1188, 1244, and 1272)."}